eCF-309

Modify Date: 2024-01-10 12:22:02

eCF-309 Structure
eCF-309 structure
Common Name eCF-309
CAS Number 2001571-40-8 Molecular Weight 383.404
Density 1.5±0.1 g/cm3 Boiling Point 642.5±65.0 °C at 760 mmHg
Molecular Formula C18H21N7O3 Melting Point N/A
MSDS N/A Flash Point 342.4±34.3 °C

 Use of eCF-309


eCF309 is a potent and highly selective mTOR inhibitor with remarkably low off-target activities (IC50 = 10-15 nM, both in vitro and in cells)[1].

 Names

Name eCF309
Synonym More Synonyms

 eCF-309 Biological Activity

Description eCF309 is a potent and highly selective mTOR inhibitor with remarkably low off-target activities (IC50 = 10-15 nM, both in vitro and in cells)[1].
Related Catalog
References

[1]. Craig Fraser, et al. eCF309: a potent, selective and cell-permeable mTOR inhibitor. Med. Chem. Commun., 2016, 7, 471-477.

 Chemical & Physical Properties

Density 1.5±0.1 g/cm3
Boiling Point 642.5±65.0 °C at 760 mmHg
Molecular Formula C18H21N7O3
Molecular Weight 383.404
Flash Point 342.4±34.3 °C
Exact Mass 383.170593
LogP 2.31
Appearance of Characters solid
Vapour Pressure 0.0±1.9 mmHg at 25°C
Index of Refraction 1.727
Storage condition Store at -20℃
Water Solubility Soluble in DMSO

 Synonyms

2-Benzoxazolamine, 5-[4-amino-1-(2,2-diethoxyethyl)-1H-pyrazolo[3,4-d]pyrimidin-3-yl]-
3-(2-Amino-1,3-benzoxazol-5-yl)-1-(2,2-diethoxyethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
Top Suppliers:I want be here



Get all suppliers and price by the below link:

eCF-309 suppliers

eCF-309 price

Related Compounds: More...
2-Propenoic acid, 2-methyl-, 3-(trimethoxysilyl)propyl ester, reaction products with silicic acid (H4SiO4) zirconium(4+) salt (1:1)
100402-80-0
Bicyclo[3.1.1]heptane-3-thiol, 2,6,6-trimethyl-, gold salt, reaction products with 4,4'-dithiobis[morpholine]
100402-52-6
disodium,[[(2R,3R,4R,5R)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-5-(3-carbamothioylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate
100063-53-4
sodium,7-[(4-amino-6-chloro-1,3,5-triazin-2-yl)amino]-4-hydroxy-3-[(2Z)-2-(6-nitro-2-oxo-4-sulfonaphthalen-1-ylidene)hydrazinyl]naphthalene-2-sulfonic acid,cobalt
100231-59-2
sodium,7-[(4-amino-6-chloro-1,3,5-triazin-2-yl)amino]-4-hydroxy-3-[(2Z)-2-(6-nitro-2-oxo-4-sulfonaphthalen-1-ylidene)hydrazinyl]naphthalene-2-sulfonic acid,chromium
100231-60-5
methyl 2-[[[5(or 6)-methyl-7(or 8)-(1-methylethyl)bicyclo[2.2.2]oct-5-en-2-yl]methylene]amino]benzoate
99688-46-7
tricopper(1+) hydrogen hexakis(cyano-C)ferrate(4-), compound with ethyl o-[6-(ethylamino)-3-(ethylimino)-2,7-dimethyl-3H-xanthen-9-yl]benzoate (1:1)
101033-43-6
Glycine, N-(2-aminoethyl)-N-[2-[(carboxymethyl)amino]ethyl]-, N,N'-bis(C8-18-branched and linear alkyl) derivs., dihydrochlorides
100208-93-3
Aluminum, 2-(1,3-dihydro-1,3-dioxo-2H-inden-2-ylidene)-1,2-dihydro-6,8-quinolinedisulfonate complexes
100402-45-7
2-(4-bromo-1H-indol-1-yl)-N-(5-methyl-1,3-thiazol-2-yl)acetamide
1219564-16-5
2-[3-(2-fluorophenyl)-6-oxopyridazin-1(6H)-yl]-N-(4-phenylbutan-2-yl)acetamide
1219545-52-4
N-(1H-benzimidazol-5-yl)-2-(2,4-dichlorophenoxy)acetamide
1219561-21-3
N-[(2Z)-5-methyl-1,3,4-thiadiazol-2(3H)-ylidene]-2-(3,5,9-trimethyl-7-oxo-7H-furo[3,2-g]chromen-6-yl)acetamide
1219548-80-7
Ethanol, 2-[[(1-methyl-1H-imidazol-2-yl)methyl]thio]-
871809-53-9
4-[4-(5-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]-4-oxo-N-(1,3-thiazol-2-yl)butanamide
1219577-06-6
1-(1H-indazole-6-carbonyl)piperidin-4-ol
1155926-98-9
2-[acetyl(2-methylpropyl)amino]-4-methyl-N-(1,3-thiazol-2-yl)-1,3-thiazole-5-carboxamide
1219539-51-1
1-[4-(2-fluorophenyl)piperazin-1-yl]-2-(5-methoxy-1H-indol-1-yl)ethanone
1219540-41-6
2-({[4-(4-chlorophenyl)-1,4,6,7-tetrahydro-5H-imidazo[4,5-c]pyridin-5-yl]carbonyl}amino)benzoic acid
1219570-45-2